Skip to main content
رجوع
TECH logo

Bio-Techne Corporation

جودة البيانات: 100%
TECH
NASDAQ Healthcare Biotechnology
KWD 52.69
▲ KWD 0.26 (0.50%)
القيمة السوقية: 8.24B
نطاق اليوم
KWD 52.02 KWD 53.23
نطاق 52 أسبوعًا
KWD 46.01 KWD 72.16
حجم التداول
1,585,370
متوسط 50 يوم / 200 يوم
KWD 60.87 / KWD 57.62
الإغلاق السابق
KWD 52.43

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 112.3 0.4
P/B 4.3 2.9
ROE % 3.7 3.9
Net Margin % 6.0 3.8
Rev Growth 5Y % 7.0 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 69.33 +31.6%
Low: KWD 62.00 High: KWD 79.00
مكرر الربحية المستقبلي
26.20
ربحية السهم المستقبلية
KWD 1.98
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.22B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 3.15
KWD 3.10 – KWD 3.21
1.71B 1
FY2029 KWD 3.03
KWD 2.98 – KWD 3.08
1.53B 1
FY2028 KWD 2.52
KWD 2.22 – KWD 2.76
1.43B 3

Dividend History

7 yr streak

Yield

0.01%

Payout Ratio

0.69%

Growth (3Y)

-37.00%

Growth (5Y)

-24.21%

Ex-Date Payment Date Amount Yield
Feb 13, 2026 Feb 27, 2026 KWD 0.08 0.53%
Nov 17, 2025 Nov 28, 2025 KWD 0.08 0.55%
Aug 18, 2025 Aug 29, 2025 KWD 0.08 0.60%
May 19, 2025 May 30, 2025 KWD 0.08 0.65%
Feb 14, 2025 Feb 28, 2025 KWD 0.08 0.49%
Nov 08, 2024 Nov 22, 2024 KWD 0.08 0.42%
Aug 19, 2024 Aug 30, 2024 KWD 0.08 0.43%
May 10, 2024 May 24, 2024 KWD 0.08 0.40%
Feb 09, 2024 Feb 26, 2024 KWD 0.08 0.47%
Nov 09, 2023 Nov 24, 2023 KWD 0.08 0.56%
Aug 17, 2023 Sep 01, 2023 KWD 0.08 0.40%
May 12, 2023 May 26, 2023 KWD 0.08 0.39%
Feb 10, 2023 Feb 27, 2023 KWD 0.08 0.42%
Nov 10, 2022 Nov 28, 2022 KWD 0.32 0.38%
Aug 12, 2022 Aug 29, 2022 KWD 0.32 0.34%
May 13, 2022 May 27, 2022 KWD 0.32 0.35%
Feb 10, 2022 Feb 25, 2022 KWD 0.32 0.30%
Nov 10, 2021 Nov 26, 2021 KWD 0.32 0.25%
Aug 13, 2021 Aug 27, 2021 KWD 0.32 0.27%
May 14, 2021 May 28, 2021 KWD 0.32 0.32%

النقاط الرئيسية

Revenue grew 6.98% annually over 5 years — modest growth
Earnings declined -56.34% over the past year
ROE of 3.68% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 256.55M in free cash flow
P/E of 112.31 — premium valuation

النمو

Revenue Growth (5Y)
6.98%
Revenue (1Y)5.23%
Earnings (1Y)-56.34%
FCF Growth (3Y)8.95%

الجودة

Return on Equity
3.68%
ROIC3.25%
Net Margin6.02%
Op. Margin8.38%

الأمان

Debt / Equity
0.23
Current Ratio3.46
Interest Coverage12.02

التقييم

P/E Ratio
112.31
Forward P/E26.20
P/B Ratio4.30
EV/EBITDA83.37
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.23% Revenue Growth (3Y) 3.58%
Earnings Growth (1Y) -56.34% Earnings Growth (3Y) -49.27%
Revenue Growth (5Y) 6.98% Earnings Growth (5Y) -14.97%
Profitability
Revenue (TTM) 1.22B Net Income (TTM) 73.40M
ROE 3.68% ROA 2.87%
Gross Margin 64.80% Operating Margin 8.38%
Net Margin 6.02% Free Cash Flow (TTM) 256.55M
ROIC 3.25% FCF Growth (3Y) 8.95%
Safety
Debt / Equity 0.23 Current Ratio 3.46
Interest Coverage 12.02
Dividends
Dividend Yield 0.01% Payout Ratio 0.69%
Dividend Growth (3Y) -37.00% Dividend Growth (5Y) -24.21%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 112.31 Forward P/E 26.20
P/B Ratio 4.30 P/S Ratio 6.76
PEG Ratio -1.97 Forward PEG N/A
EV/EBITDA 83.37 Fwd EV/EBITDA 23.32
Forward P/S 6.73 Fwd Earnings Yield 3.82%
FCF Yield 3.11%
Market Cap 8.24B Enterprise Value 8.53B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.22B 1.16B 1.14B 1.11B 931.03M
Net Income 73.40M 168.11M 285.26M 272.05M 140.41M
EPS (Diluted) 0.46 1.05 1.76 1.66 0.87
Gross Profit 790.27M 769.73M 769.82M 756.50M 632.85M
Operating Income 102.26M 206.69M 298.94M 296.59M 237.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.56B 2.70B 2.64B 2.29B 2.26B
Total Liabilities 639.06M 635.02M 672.18M 593.79M 691.72M
Shareholders' Equity 1.92B 2.07B 1.97B 1.70B 1.56B
Total Debt 444.06M 419.54M 454.97M 325.97M 420.55M
Cash & Equivalents 162.19M 151.79M 180.57M 172.57M 199.09M
Current Assets 608.30M 617.42M 621.48M 605.56M 510.61M
Current Liabilities 175.85M 159.38M 128.51M 176.02M 152.28M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#884 of 1052
28

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026